Fortrea Holdings Inc. (FTRE) vs NeoGenomics, Inc. (NEO)
A side-by-side comparison of Fortrea Holdings Inc. and NeoGenomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.
FTRE
Fortrea Holdings Inc.
$20.00HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
NEO
NeoGenomics, Inc.
$18.47HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
Total return — FTRE vs NEO
growth of $100 · dividends reinvested · last 3yFTRE -37.5% (-14.5%/yr)NEO +6.6% (+2.2%/yr)NEO compounded faster over this window
FTRE NEO
FTRE vs NEO: by the numbers
- •FTRE is the larger company ($1.90B vs $475M market cap).
- •Both run net losses; FTRE's is the smaller (-3.18% vs -6.77% net margin).
- •NEO grew revenue faster over the past five years (9.41% vs 1.09% CAGR).
Metrics side by side
Valuation
| Metric | FTRE | NEO |
|---|---|---|
| Forward P/E | 23.78 | 101.08 |
| P/S ratio | 0.71 | 0.62 |
| P/B ratio | 3.63 | 0.60 |
| EV / EBITDA | 31.92 | N/A |
| FCF yield | 7.92% | N/A |
Profitability
| Metric | FTRE | NEO |
|---|---|---|
| Gross margin | 17.11% | 42.92% |
| Operating margin | 0.41% | -8.63% |
| Net margin | -3.18% | -6.77% |
| ROE | -16.25% | -6.60% |
| ROIC | 0.62% | -5.29% |
Growth (annualized)
| Metric | FTRE | NEO |
|---|---|---|
| Revenue CAGR (5Y) | 1.09% | 9.41% |
| FCF CAGR (5Y) | -12.98% | N/A |
| Total return CAGR (5Y) | N/A | -17.55% |
Frequently asked
- Which has grown faster, FTRE or NEO?
- Over the past five years, NEO grew revenue faster — FTRE at a 1.09% CAGR versus NEO at 9.41%.
Go deeper
Dig into the metrics
Fortrea ROENeoGenomics ROEFortrea operating marginNeoGenomics operating marginFortrea revenue growthNeoGenomics revenue growthFortrea free cash flowNeoGenomics free cash flow
Fortrea & NeoGenomics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.